Maxcyte (MXCT) Return on Capital Employed (2021 - 2026)
Maxcyte (MXCT) posted quarterly Return on Capital Employed of 24.32% for Q1 2026, down 125.0% year-over-year from 97.28% in Q1 2025, and up 9.22% quarter-over-quarter from 26.79% in Q4 2025.
Maxcyte (MXCT) Return on Capital Employed (2021 - 2026) Analysis & Trends
Maxcyte (MXCT) has reported Return on Capital Employed for 6 consecutive years, with 24.32% the latest figure, recorded in Q1 2026.
- In Q1 2026, Return on Capital Employed fell 125.0% year-over-year to 24.32%; the TTM figure through Mar 2026 stood at 24.32% (down 125.0% YoY), while the FY2025 annual figure was 25.1%, down 360.0% from the prior year.
- Return on Capital Employed improved to 24.32% in Q1 2026 per MXCT's latest filing, from 26.79% in the prior quarter.
- Across five years, Return on Capital Employed topped out at 5.87% in Q1 2022 and bottomed at 26.79% in Q4 2025.
- Historically, Return on Capital Employed has averaged 18.02% across 5 years, with a median of 19.09% in 2024.
- Annual changes were most pronounced in 2022 — Return on Capital Employed plunged 39 bps — and 2023, when it tumbled 925 bps.
- Maxcyte's Return on Capital Employed stood at 10.09% in 2022, then plunged by 92 bps to 19.35% in 2023, then slipped by 16 bps to 22.43% in 2024, then decreased by 19 bps to 26.79% in 2025, then increased by 9 bps to 24.32% in 2026.
- Business Quant data shows MXCT's Return on Capital Employed at 24.32% in Q1 2026, 26.79% in Q4 2025, and 26.72% in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROCE (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 199.47 Bn | 193.87 Bn | 7.27 Bn | 7.98% |
| 2 | Stryker | 129.69 Bn | 126.21 Bn | 4.50 Bn | 13.69% |
| 3 | Medtronic | 119.67 Bn | 110.45 Bn | 6.41 Bn | 8.02% |
| 4 | Boston Scientific | 73.68 Bn | 73.14 Bn | 3.85 Bn | 10.83% |
| 5 | Edwards Lifesciences | 52.38 Bn | 48.13 Bn | 1.35 Bn | 11.99% |
| 6 | Dexcom | 34.76 Bn | 32.82 Bn | 830.00 Mn | 27.21% |
| 7 | GE HealthCare Technologies | 34.15 Bn | 32.04 Bn | 2.18 Bn | 9.47% |
| 8 | Koninklijke Philips | 26.43 Bn | 23.11 Bn | 4.55 Bn | 12.84% |
| 9 | Steris | 23.25 Bn | 22.77 Bn | 684.20 Mn | 12.08% |
| 10 | Maxcyte | 147.95 Mn | 147.95 Mn | 5.60 Mn | -23.26% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -23.26% |
| Mar 31, 2026 | -24.32% |
| Dec 31, 2025 | -26.79% |
| Sep 30, 2025 | -26.72% |
| Jun 30, 2025 | -25.07% |
| Mar 31, 2025 | -23.07% |
| Dec 31, 2024 | -22.43% |
| Sep 30, 2024 | -19.96% |
| Jun 30, 2024 | -19.09% |
| Mar 31, 2024 | -18.99% |
| Dec 31, 2023 | -19.35% |
| Sep 30, 2023 | -18.61% |
| Jun 30, 2023 | -15.47% |
| Mar 31, 2023 | -13.60% |
| Dec 31, 2022 | -10.09% |
| Sep 30, 2022 | -9.42% |
| Jun 30, 2022 | -7.45% |
| Mar 31, 2022 | -5.87% |
| Dec 31, 2021 | -6.86% |
| Sep 30, 2021 | -9.03% |